'Overworked and Burned Out': What We Heard This Week

"It calls attention to how overworked and burned out so many of us are." -- Brandon Peplinski, MD, of the University of Washington, discussing a residents' "sick in" to protest stalled contract negotiations.

"I now believe that it is essential to review older clinicians." -- Leo Cooney, MD, of Yale Medical School, discussing Yale New Haven Hospital's policy to implement mandatory cognitive testing of clinicians age 70 and older.

"People say 'Oh, this week, there's been a slight decline' -- they shouldn't be lulled into a false sense of security." -- Aaron Glatt, MD, spokesperson for the Infectious diseases Society of America, on this influenza B dominant flu season.

"They can't conduct cannabis research until they can show cannabis has a medical use, but they can't demonstrate cannabis has a medical use until they conduct research. It doesn't make sense." -- Rep. Anna Eshoo (D-Calif.), chair of the House Energy and Commerce Health Subcommittee, in a hearing called to discuss the health effects of cannabis.

"People are being put in a position where they're putting their health at risk because of affordability." -- Bari Talente, of the National Multiple Sclerosis Society, talking about the rising cost of MS drugs.

Continue reading
  14 Hits
14 Hits

US presidential hopeful Bloomberg plans to ban all flavored vapes

January 17, 2020

Democratic presidential candidate Mike Bloomberg on Tuesday said he would ban the sale of all flavored e-cigarettes and raise taxes on traditional cigarettes if he wins the White House, according to an article posted on thehill.com. 

Bloomberg, the former mayor of New York City, said he would also push to reduce the amount of nicotine in traditional cigarettes, e-cigarettes and other tobacco products to “nonaddictive levels.”

Tobacco control has been one of Bloomberg’s top priorities as a philanthropist and as a politician, according to the article. 

Bloomberg Philanthropies announced in September a $160 million initiative to “end the youth e-cigarette epidemic.” 

Continue reading
  11 Hits
Tags:
11 Hits

Boster's Multiple Sclerosis Vlog: MS Diet [2020]

Boster's  Multiple Sclerosis Vlog: MS Diet [2020]



In this video I share my evolving opinions on diet and MS in 2020.
To learn more about nutrition and Multiple Sclerosis, start watching this video right now!


Click HERE to Register for the MS Beacon Newsletter



.................................................................................................

CLICK Red BOX to SUBSCRIBE to the MS Learning Channel on YouTube

Click Red Box on banner to opt-in
........................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Original author: Stuart
  49 Hits
49 Hits

Got MS Brain Fog? These 4 Foods Can Help


Your brain works hard all day long, so feed it well. Your diet can easily influence your emotions, ability to focus, energy levels, and so much more. A nutritionist shares her favorite brain-boosting foods and how to get them in your diet.


We all feel pretty tired every now and then. Our brains might feel foggy, or we just feel mentally (and physically) exhausted.
hare on Pinterest
The good news is that, just like a diet that’ll help your digestive health or immunity, there’s brain food out there that can help promote your energy and fight fatigue.
Certain vitamins and minerals in foods can even help keep your brain sharp by battling a foggy mind or even memory loss. You can also get certain nutrients from food that will make you feel more awake and ready to tackle your day.
To help strengthen and energize your mind, here are some of my favorite “brain foods” — plus ideas for how to work them into your everyday wellness routine.
SALMON
The omega-3 fatty acids in fish keep your brain at the top of its game. This healthy type of polyunsaturated fatty acid is found in abundance in salmon and has been shown to help fight fatigue.
More specifically, one study found that those with chronic fatigue syndrome could benefit from adding more omega-3s to their diet. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both of which are found in salmon, actually helped those with chronic fatigue.
Other researchTrusted Source focusing on children actually found that those who eat fish more frequently get a better night’s rest, which translates to better energy the next day.
To add more good news: Other scienceTrusted Source says that the omega-3 in fish can even keep your mind sharp by fighting off Alzheimer’s disease.
As you can see, there are several benefits to adding fish to your meal plan.

How to get it in your diet

Aim to eat two servings of a fish a week. One serving is 2 to 3 ounces, about the size of your palm. Look for wild-caught rather than farm-raised salmon for more nutrient-dense fish.
You can purchase wild fish at most grocery stores. Just look on the label for details on where it’s coming from. You should easily be able to spot the “wild caught” stamp.
A healthy way to prepare fish is either baked in the oven or on the stovetop. You can add veggies and bake in foil for a quick, delicious meal.
Another one of my favorite dishes, which you can easily add wild-caught fish to, is a nourishing macro bowl. Check out how to make your own with these tips.

2. Olive oil

A staple of the Mediterranean diet, olive oil may help protect memory and learning ability and reduce the risk of Alzheimer’s disease, suggests a study on mice. These health benefits of olive oil likely come from vitamin E (which can also help boost immunity) and other antioxidants that help fight off free radicals in the body and brain.
Olive oil also provides anti-inflammatory benefits that can help fight off illnesses throughout the body, including the brain. Lowering inflammation can help counteract fatigue, too.
CLICK HERE to continue reading
.................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
(Originally posted by Stuart)
  46 Hits
46 Hits

Researchers Discover Molecular Switch That Repairs Neurological Damage - Interesting Engineering

Curing disorders such as multiple sclerosis could one day be as simple as turning on a molecular switch thanks to new research by Isobel Scarisbrick, Ph.D., published in the Journal of Neuroscience. Her work finds that by genetically switching off a receptor activated by blood proteins, named Protease Activated Receptor 1 (PAR1), the body switches on regeneration of myelin.

RELATED: NEW MOLECULE LINKED TO STOPPING AND REVERSING NEURO DAMAGE DONE BY PARKINSON’S DISEASE

Improving function

"Myelin regeneration holds tremendous potential to improve function. We showed when we block the PAR1 receptor, neurological healing is much better and happens more quickly. In many cases, the nervous system does have a good capacity for innate repair," said Dr. Scarisbrick, principal investigator, and senior author. "This sets the stage for development of new clinically relevant myelin regeneration strategies."

Myelin is an insulating layer, made up of protein and fatty substances, that forms around nerves, including those in the brain and spinal cord. It protects electrical signals sent through the nervous system. 

Once myelin is injured, electrical signals between brain cells are slowed down. This results in the loss of sensory and motor function you so often see in disorders such as Multiple Sclerosis.

Continue reading
  62 Hits
62 Hits

Robotic exoskeleton helps woman with multiple sclerosis walk - WJXT News4JAX

Sign up for our Newsletters

Latest News

Health

Despite having Multiple Sclerosis, Kathy Miska can walk with the assistance of a robotic exoskeleton that is programmed to meet her needs. (Cleveland Clinic News Service)

Kathy Miska, 56, of Strongsville, Ohio is fighting Multiple Sclerosis one step at a time.

Multiple Sclerosis, or MS, disrupts signals from the brain and often robs people of their mobility.

Miska is one of five MS patients at Cleveland Clinic taking part in a research study to see if a special robotic brace, or exoskeleton, will benefit her mobility.

“By doing what we would call a ‘forced use,’ the hope is that you’ll reprogram the brain so that it actually can work better and create better walking,” said Francois Bethoux, M.D., Chair of Cleveland Clinic’s Department of Physical Medicine and Rehabilitation and principal investigator of the study.

The device is programmed to each person who uses it. Braces support the lower body and carry the user. Motors are triggered by sensors to lift the legs, assisting the patient to walk.

Continue reading
  72 Hits
72 Hits

Principia Biopharma - The Future Worsens - Seeking Alpha

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Reference ID:

  42 Hits
42 Hits

GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Sales Grow - Barron's

Text size

An employee holds a crate of bottles Epidiolex, a cannabinoid-based medicine, at the GW Pharmaceuticals facility in Sittingbourne, U.K. Photograph by Jason Alden/Bloomberg

Ahead of its appearance at this week’s J.P. Morgan Healthcare Conference, GW Pharmaceuticals, the only company with an approved drug derived from cannabis, says that 2019 sales came in better than expected.

The British drug company said on Sunday that its seizure treatment Epidiolex achieved sales of $104 million in the December quarter and $296 million in 2019—its first year of sales.

Its stock (ticker: GWPH) rose 5% on the news, to $113.31. Its preannounced sales for the fourth quarter were somewhat better than predicted by admirers like Guggenheim’s Yatin Suneja, and the analyst wrote on Monday that he came away reassured about his Buy rating after talking to GW’s management.

A rush of Buy recommendations followed the launch of Epidiolex after the U.S. Food and Drug Administration approved it as a treatment for difficult forms of epilepsy. The drug started strong, and GW stock soared to $196 a share, before sinking amid the cannabis sector selloff in last year’s second half.

Continue reading
  63 Hits
63 Hits

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen - P&T Community

BOSTON, Jan. 13, 2020 /PRNewswire/ -- Concerto HealthAI, a market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today that it has entered into a multi-disease collaboration with Janssen Research & Development, LLC (Janssen). The collaboration will allow Janssen to access Concerto HealthAI's use-case engineered RWD, enterprise AI solutions, and scientific services. Concerto HealthAI has the most comprehensive, representative, and independently sourced RWD in the industry as part of an exclusive licensing agreement with the American Society of Clinical Oncology's CancerLinQ® program, and partnerships with clinically integrated community oncology networks, and other partners.

Janssen gains access to Concerto HealthAI's powerful suite of use-case engineered RWD products in the new eurekaHealth 3.0 enterprise AI solution. eurekaHealth integrates and enriches multiple sources to provide a holistic view of the patient journey with greater clinical depth to support translational sciences, clinical study design, and RWD applications for regulatory submissions. eurekaHealth 3.0 is the only enterprise-grade solution to exceed 21CFRPart11 compliance requirements and serve as an intelligence layer, integrating into research and clinical development workflows across the enterprise. Janssen will be the first to use Concerto HealthAI's Genome360™, a translational-grade, first-in-class, real-world solution in development that integrates in-depth clinical and next-generation sequencing characterization of a patient's cancer.

"We believe our mission and responsibility as a leader in Precision Oncology aligns well with Janssen's innovation focus in data science," said Jeff Elton, PhD, CEO of Concerto HealthAI. "We are excited to bring our unique integration of RWD, technology applications, and data science expertise to collaborate with Janssen's researchers and data scientists to optimize drug development for patients."

About Concerto HealthAI
Concerto HealthAI, a SymphonyAI Group portfolio company, is a technology leader in definitive Real-World Data (RWD) and AI solutions for Precision Oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. For more information, visit us at http://www.concertohealthai.com.

View original content:http://www.prnewswire.com/news-releases/concerto-healthai-establishes-real-world-data-and-ai-collaboration-with-janssen-300985616.html

Continue reading
  46 Hits
46 Hits

Cortica Announces Leadership Appointments And Strategic Investment By Ajax Health And Questa Capital - P&T Community

SAN DIEGO, Jan. 13, 2020 /PRNewswire/ -- Cortica Inc. ("Cortica"), a leading provider of advanced neurological therapies for children with autism and other neurodevelopmental conditions, announced today leadership appointments to further its mission to design and deliver life-changing care – one child, one family, one community at a time.

"We are thrilled to have attracted a team of leaders and investor partners with a proven record of success and an unwavering commitment to helping children with neurodevelopmental differences and their families," said Neil Hattangadi, MD, Co-Founder and Chief Executive Officer at Cortica. "These leaders will help us accelerate the rollout of our comprehensive care model for autism nationally and support ongoing technological innovation for clinical care delivery and the patient experience."

The following operational leadership team will help position Cortica for its next phase of growth.

Daniel Virnich, MD, MBA, Chief Operating Officer: Dr. Virnich brings over 15 years of healthcare leadership experience to Cortica. He was previously President, Florida Market, for DaVita, Inc./Healthcare Partners. In this role he was responsible for growth, operations, and clinical quality of a $1 billion delegated medical group, serving approximately 100,000 Medicare Advantage patients. He previously served as Senior Vice President, California Market, for DaVita and National Chief Medical Officer, Acute Care Services, for Team Health Inc. Dr. Virnich earned his MD from the University of Chicago and his MBA from the Kellogg School of Management at Northwestern; he completed his clinical training at UCLA Medical Center and is board-certified in Internal Medicine.

"Cortica has developed an innovative, neuroscience-based care model to treat a very important and underserved population," said Dr. Virnich. "As COO, I am committed to operational excellence that enables strong clinical outcomes, a great experience for families and the well-being of Cortica's team members."

Continue reading
  7 Hits
7 Hits

The $432B Medical Devices Market: Worldwide Trends, Forecasts and Competitive Analyses (2014-2025) - P&T Community

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The "Medical Device Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

The medical device market is expected to reach an estimated $432.6 billion by 2025, and it is forecast to grow at a CAGR of 4.1% from 2020 to 2025.

Some features of this report include:

Market size estimates: Medical device market size estimation in terms of value ($B) shipment. Trend and forecast analysis: Market trend (2014-2019) and forecast (2020-2025) by region, application and end-user industry Segmentation analysis: Medical device market size by application, function, and end-use in terms of value and volume shipment. Regional analysis: Medical device market breakdown by key regions such as North America, Europe, and Asia & Rest of World. Growth opportunities: Analysis on growth opportunities in different applications and regions of a medical device in the medical device market. Strategic analysis: This includes M&A, new product development, and competitive landscape of medical device in the medical device market. Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

The future of the medical device market looks good with opportunities in the hospital and homecare sectors. The major drivers for market growth are increasing healthcare expenditure, technological development, growing aging population, and chronic diseases.

Emerging trends, which have a direct impact on the dynamics of the medical device industry, include increasing use of AI-Optimized medical device, increasing acceptance of wearable medical devices, growing use of miniaturized medical devices, and growing adoption 3D-Printing in medical devices.

Continue reading
  438 Hits
438 Hits

Your Everyday Guide to Living Well With MS

Your Everyday Guide to Living Well With MS
By Becky Upham -  Medically Reviewed by Samuel Mackenzie, MD, PhD
January 2020

Following a healthy diet is one part of living well with Multiple Sclerosis.
Getty Images


If you have Multiple Sclerosis (MS) or know someone who does, you know that a big piece of living with the condition is the heightened uncertainty of what each day may bring; the ups and downs of the condition are well beyond what most healthy people can understand. Even if you’ve grown to accept your “new normal,” it doesn’t necessarily make it any easier. Learning about the additional challenges that may come along and how to navigate them can make a huge difference in quality of life, both for you and those around you.

The following tips, tools, and resources can help you to live well with Multiple Sclerosis.

Click HERE to Register for the MS Beacon Newsletter


Managing Daily Life and Complications of MS

Paying attention to your symptoms and how your body feels is critical to staying healthy when you have MS. Pushing too hard for too long can lead to a Worsening of symptoms or even a flare-up, or relapse. But adhering to a healthy lifestyle can be easier said than done as many of the challenges of MS — lack of mobility, financial strains, or even depression — often make even harder to do what you know you should do. Figuring out what works for you — and what doesn’t — can help you live your best life with MS.

Diet for MS

How what we eat can improve or worsen various chronic illnesses is a growing area of research. Although some people with MS may experience some symptom relief when they eliminate or add certain foods to their diet, there’s no evidence yet that any particular diet can impact disease progression in MS.
It’s a good idea to discuss any specific dietary changes you’d like to make with your doctor; some popular diets could have a negative impact on MS. Currently, the diet recommended for MS is similar to what’s recommended for everyone: lots of fiber, fruits, and vegetables, and limits on the amounts of unhealthy fats and sugar you eat. Staying at a healthy weight is important for everyone but particularly if you have MS. Having obesity can increase your risk for fatigue and depression, and obesity in children and teens has been associated with an increased risk for MS later in life.

Exercising With MS

Although the fatigue and pain that often comes with MS can make physical activity difficult, exercising can improve mobility and make you feel better. A physical therapist or specially trained exercise professional can share specific exercises designed to improve foot drop, walking, balance, and going from sitting to standing.
It’s also possible to increase your strength, flexibility, and level of fitness when you have MS. Although exercise can lead to soreness and fatigue, working with an expert can help ensure sure you don’t overdo it. A consistent program that builds your strength and stamina can actually help reduce fatigue in the long run.

Managing Your Prescriptions for MS

When it comes to medication to treat MS, there are more options than ever before — currently, there are 18 approved disease-modifying therapies. Once you’re diagnosed and you and your neurologist decide the best medication for your situation, you’ll want to start treatment as soon as possible.
“Whether you have a slowly or rapidly progressing form of MS, a disease-modifying therapy will reduce the relapse rate by up to 50 percent,” says Michael Hutchinson, MD, PhD, an associate clinical professor of neurology at the Icahn School of Medicine at Mount Sinai in New York City.
Once your doctor decides what therapy is right for you, you’ll be shown the correct way to take your medicine. It can take time to determine if the drug is working appropriately or whether or not you should switch medication. In many cases, you’ll need to have periodic blood tests to make sure your body is metabolizing and responding to the medication appropriately.
Continue Reading


.................................................................................................

CLICK Red BOX to SUBSCRIBE to the MS Learning Channel on YouTube

Click Red Box on banner to opt-in
........................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
(Originally posted by Stuart)
  49 Hits
49 Hits

Learning about FSA and HSA Cards for healthcare savings

Learning about FSA and HSA Cards for healthcare savings
What Are FSA & HSA cards?

FSA Debit Card is a type of debit card issued in the United States. It can access tax-favored spending accounts such as flexible spending accounts (FSA) and health reimbursement accounts (HRA), and sometimes health savings accounts (HSA) as well.

A health savings account (HSA) and a flexible spending account (or FSA, also called a flexible spending arrangement by the IRS) are both tax-advantaged accounts that allow you to save specifically for medical costs.


What is the difference between an FSA and HSA account?

The most significant difference between flexible spending accounts (FSA) and health savings accounts (HSA) is that an individual controls an HSA and allows contributions to roll over, while FSAs are less flexible and are owned by an employer.


Click HERE to Register for the MS Beacon Newsletter


HSA vs. FSA: Differences and How to Choose

Both HSAs and FSAs provide tax savings on health costs, but you'll have to buy a medical plan that pays few costs upfront to qualify for an HSA, and not everybody should.

CLICK HERE to Learn More


.................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
(Originally posted by Stuart)
  18 Hits
18 Hits

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals

 Jan 10, 2020 | By Inez Cornell, Radleys



Credit: Shutterstock

Click HERE to Register for the MS Beacon Newsletter


Whilst there are many countries in Europe where possession of cannabis is decriminalized, such as Czech Republic, Switzerland, Spain and The Netherlands, in the UK, possession of the Class B drug is still illegal. It is expected, however, that the laws around cannabis may be relaxed within the UK, as in November 2018, specialist doctors were given the go ahead to prescribe cannabis-derived medicines.
A recent 
study showed that despite 72% of UK citizens with a disability or chronic illness claiming they experienced a great improvement to their symptoms when using cannabis, 43% of those suffering from medical conditions do not use cannabis to relieve their symptoms or pains, due to the drug being illegal. 
The same study also showed that 54% of people living in the UK with a chronic illness, believed they should be legally allowed to purchase cannabis to help relieve symptoms.

A drug that contains two chemical extracts derived from the cannabis plant, called Sativex has previously received regulatory approval, but only available through private prescription in England. Used to treat epilepsy and Multiple Sclerosis, the drug is now available via NHS prescription.

It is expected that pharmaceutical companies will use cannabis to develop even more products which will help treat rare and catastrophic illnesses and conditions. So, it can be expected that the UK will follow in the footsteps of countries such as the US, the Netherlands, Germany, Austria, and Croatia which have legalized cannabinoids for medicinal use.

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and #cannabinoids. 

Cannabinoids can be classified in three groups: phytocannabinoids, endocannabinoids, and synthetic analogues of both groups. There are many companies out there which are dedicated to developing and commercializing cannabis-based products and cannabinoid medicines, which will help with health issues such as skin conditions, epilepsy, Multiple Sclerosis (MS), and pain.

Read more


#cannabinoids, #MS, #MultipleSclerosis, #Sativex, #NHS,  #UK, #Europe, #Cannabis

........................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
(Originally posted by Stuart)
  46 Hits
46 Hits

A molecular switch for repairing damage in central nervous system disorders discovered

Reviewed by Kate Anderton, B.Sc. (Editor)Jan 11 2020

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as Multiple Sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.

Research by Isobel Scarisbrick, Ph.D., published in the Journal of Neuroscience finds that by genetically switching off a receptor activated by blood proteins, named Protease Activated Receptor 1 (PAR1), the body switches on regeneration of myelin, a fatty substance that coats and protects nerves.

Myelin regeneration holds tremendous potential to improve function. We showed when we block the PAR1 receptor, neurological healing is much better and happens more quickly. In many cases, the nervous system does have a good capacity for innate repair. This sets the stage for development of new clinically relevant myelin regeneration strategies."

Dr. Isobel Scarisbrick, principal investigator and senior author

Continue reading
  47 Hits
47 Hits

My MS Toolkit - (a must read)

  Called My #MSToolkit, the tool is a free and web-based, self-guided program based on behavioral healthcare. It's designed to help in managing such symptoms as pain, fatigue, and depression or mood swings, and to assist people in finding ways to minimize their impact on quality of life


  

CLICK to read all there is to know, directly from the MS ToolKit Website

 `````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````

ALSO, Click HERE to Register for the MS Beacon Newsletter


My MS Toolkit was born out of a realization that access to symptom self-management care for people with Multiple Sclerosis (MS) is extremely limited. To better meet the needs of people with MS, a group of four clinical psychologists – Drs. Kratz, Williams, Ehde, and Alschuler – partnered to develop this web-based, self-guided, symptom self-management program specifically for people living with MS symptoms.
My MS Toolkit is based on a number of existing evidence-based symptom self-management resources, including the telephone-delivered intervention for MS, called “Take Charge”, and the web-based intervention for fibromyalgia symptoms, called “FibroGuide”.  Both Take Charge and FibroGuide have been tested in clinical trials, and have been shown to be effective in reducing the severity and impact of symptoms (see references below).


........................................................................................................

This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
(Originally posted by Stuart)
  51 Hits
51 Hits

Molecular switch for repairing central nervous system disorders

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as Multiple Sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.

Research by Isobel Scarisbrick, Ph.D., published in the Journal of Neuroscience finds that by genetically switching off a receptor activated by blood proteins, named Protease Activated Receptor 1 (PAR1), the body switches on regeneration of myelin, a fatty substance that coats and protects nerves.

"Myelin regeneration holds tremendous potential to improve function. We showed when we block the PAR1 receptor, neurological healing is much better and happens more quickly. In many cases, the nervous system does have a good capacity for innate repair," says Dr. Scarisbrick, principal investigator and senior author. "This sets the stage for development of new clinically relevant myelin regeneration strategies."

Myelin, Thrombin and the Nervous System

Myelin acts like a wire insulator that protects electrical signals sent through the nervous system. Demyelination, or injury to the myelin, slows electrical signals between brain cells, resulting in loss of sensory and motor function. Sometimes the damage is permanent. Demyelination is found in disorders such as MS, Alzheimer's disease, Huntington's disease, schizophrenia and spinal cord injury.

Continue reading
  25 Hits
25 Hits

Missing one night of sleep may increase Alzheimer's biomarker, study finds

Reviewed by Kate Anderton, B.Sc. (Editor)Jan 8 2020

A preliminary study has found that when young, healthy men were deprived of just one night of sleep, they had higher levels of tau, a biomarker for Alzheimer's disease, in their blood than when they had a full, uninterrupted night of rest. The study is published in the January 8, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Tau is a protein found in neurons that can form into tangles. These accumulate in the brains of people with Alzheimer's disease. It can start to develop in the brain decades before symptoms of the disease appear. Previous studies of older adults have suggested that sleep deprivation can increase the level of tau in the cerebral spinal fluid. Trauma to the head can also increase circulating concentrations of tau in blood.

Many of us experience sleep deprivation at some point in our lives due to jet lag, pulling an all-nighter to complete a project, or even doing shift work, working overnights or inconsistent hours. Our exploratory study shows that even in young, healthy individuals, missing one night of sleep increases the level of tau in blood suggesting that over time, such sleep deprivation could possibly have detrimental effects."

Jonathan Cedernaes, MD, PhD, study author, Uppsala University in Sweden

Continue reading
  1 Hits
1 Hits

Juul Labs taps Cartwright to lead restructuring team; promotes Sinha as interim CFO

January 8, 2020

E-cigarette maker Juul Labs Inc has named Chief Financial Officer Guy Cartwright as its chief transformation officer, a company spokesman told Reuters on Monday.

The spokesman said Cartwright would continue to focus on a restructuring at the company, which includes reducing operating expenses by $1 billion and aligning budget to key priorities.

The company appointed Chief Accounting Officer Saurabh Sinha as interim CFO, the spokesman added, according to the story. 

Category: Breaking News

Original author: GTNF Trust
  82 Hits
Tags:
82 Hits

Public hearing coming for proposed flavor ban in US state of Rhode Island

January 8, 2020

In the US state of Rhode Island, public health officials have announced a public hearing on proposed regulations to permanently ban the sale of flavored vaping products in the state.

The state Department of Health said the hearing is scheduled for Tuesday in Providence, according to an article on apnews.com.

The department is considering making the temporary ban currently in effect in Rhode Island permanent.

Democratic Gov. Gina Raimondo signed an executive order in September banning the sale of flavored vaping products. In response, the Health Department issued emergency regulations Oct. 4 to implement a four-month ban, with an optional two-month extension, according to the article.

Continue reading
  70 Hits
Tags:
70 Hits
 
 

Follow Us on Twitter

Follow Us On Twitter - Image